DEXCOM, INC. Impairment of Long-Lived Assets Held-for-use
DEXCOM, INC. (DXCM) reported Impairment of Long-Lived Assets Held-for-use of $0 for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-04-30.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:ImpairmentOfLongLivedAssetsHeldForUse · last filed 2026-04-30
- DEXCOM, INC. impairment of long-lived assets held-for-use for the quarter ending 2026-03-31 was $0.00.
- DEXCOM, INC. impairment of long-lived assets held-for-use for the quarter ending 2025-12-31 was $0.00.
- DEXCOM, INC. impairment of long-lived assets held-for-use for the quarter ending 2025-09-30 was $0.00.
- DEXCOM, INC. impairment of long-lived assets held-for-use for the quarter ending 2025-06-30 was $0.00.
- DEXCOM, INC. impairment of long-lived assets held-for-use for fiscal 2025 was $0.00.
- DEXCOM, INC. impairment of long-lived assets held-for-use for fiscal 2024 was $0.00.
- DEXCOM, INC. impairment of long-lived assets held-for-use for fiscal 2023 was $0.00, a 100.00% decline from fiscal 2022.
- DEXCOM, INC. impairment of long-lived assets held-for-use for fiscal 2022 was $23.00M.
| Period end | Impairment of Long-Lived Assets Held-for-use 3 month | Impairment of Long-Lived Assets Held-for-use 6 month | Impairment of Long-Lived Assets Held-for-use 9 month | Impairment of Long-Lived Assets Held-for-use 12 month |
|---|---|---|---|---|
| 2026-03-31 | $0.00 10-Q · filed 2026-04-30 | $0.00 derived: sum of 2 quarters · filed 2026-04-30 | $0.00 derived: sum of 3 quarters · filed 2026-04-30 | $0.00 derived: sum of 4 quarters · filed 2026-04-30 |
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-12 | $0.00 derived: sum of 2 quarters · filed 2026-02-12 | $0.00 derived: sum of 3 quarters · filed 2026-02-12 | $0.00 10-K · filed 2026-02-12 |
| 2025-09-30 | $0.00 10-Q · filed 2025-10-30 | $0.00 derived: sum of 2 quarters · filed 2025-10-30 | $0.00 10-Q · filed 2025-10-30 | $0.00 derived: sum of 4 quarters · filed 2026-04-30 |
| 2025-06-30 | $0.00 10-Q · filed 2025-07-30 | $0.00 10-Q · filed 2025-07-30 | $0.00 derived: sum of 3 quarters · filed 2026-04-30 | $0.00 derived: sum of 4 quarters · filed 2026-04-30 |
| 2025-03-31 | $0.00 10-Q · filed 2026-04-30 | $0.00 derived: sum of 2 quarters · filed 2026-04-30 | $0.00 derived: sum of 3 quarters · filed 2026-04-30 | $0.00 derived: sum of 4 quarters · filed 2026-04-30 |
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-12 | $0.00 derived: sum of 2 quarters · filed 2026-02-12 | $0.00 derived: sum of 3 quarters · filed 2026-02-12 | $0.00 10-K · filed 2026-02-12 |
| 2024-09-30 | $0.00 10-Q · filed 2025-10-30 | $0.00 derived: sum of 2 quarters · filed 2025-10-30 | $0.00 10-Q · filed 2025-10-30 | $0.00 derived: sum of 4 quarters · filed 2026-02-12 |
| 2024-06-30 | $0.00 10-Q · filed 2025-07-30 | $0.00 10-Q · filed 2025-07-30 | $0.00 derived: sum of 3 quarters · filed 2026-02-12 | $0.00 derived: sum of 4 quarters · filed 2026-02-12 |
| 2024-03-31 | $0.00 10-Q · filed 2025-05-01 | $0.00 derived: sum of 2 quarters · filed 2026-02-12 | $0.00 derived: sum of 3 quarters · filed 2026-02-12 | $0.00 derived: sum of 4 quarters · filed 2026-02-12 |
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-12 | $0.00 derived: sum of 2 quarters · filed 2026-02-12 | $0.00 derived: sum of 3 quarters · filed 2026-02-12 | $0.00 10-K · filed 2026-02-12 |
| 2023-09-30 | $0.00 10-Q · filed 2024-10-24 | $0.00 derived: sum of 2 quarters · filed 2024-10-24 | $0.00 10-Q · filed 2024-10-24 | $23.00M derived: sum of 4 quarters · filed 2025-02-18 |
| 2023-06-30 | $0.00 10-Q · filed 2024-07-25 | $0.00 10-Q · filed 2024-07-25 | $23.00M derived: sum of 3 quarters · filed 2025-02-18 | $23.00M derived: sum of 4 quarters · filed 2025-02-18 |
| 2023-03-31 | $0.00 10-Q · filed 2024-04-25 | $23.00M derived: sum of 2 quarters · filed 2025-02-18 | $23.00M derived: sum of 3 quarters · filed 2025-02-18 | $23.00M derived: sum of 4 quarters · filed 2025-02-18 |
| 2022-12-31 | $23.00M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-18 | $23.00M derived: sum of 2 quarters · filed 2025-02-18 | $23.00M derived: sum of 3 quarters · filed 2025-02-18 | $23.00M 10-K · filed 2025-02-18 |
| 2022-09-30 | $0.00 10-Q · filed 2023-10-26 | $0.00 derived: sum of 2 quarters · filed 2023-10-26 | $0.00 10-Q · filed 2023-10-26 | |
| 2022-06-30 | $0.00 10-Q · filed 2023-07-27 | $0.00 10-Q · filed 2023-07-27 | ||
| 2022-03-31 | $0.00 10-Q · filed 2023-04-27 | |||
| 2021-12-31 | $0.00 10-K · filed 2024-02-08 | |||
| 2020-12-31 | $0.00 10-K · filed 2023-02-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| WEST PHARMACEUTICAL SERVICES INC (WST) | United States | $26.288B | 43.14 |
| BECTON DICKINSON & CO (BDX) | United States | $48.834B | 43.79 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |
| GLAUKOS Corp (GKOS) | United States | $9.135B | -43.73 |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |